These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20590708)

  • 1. Sclerosants: a comparative review.
    Duffy DM
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1010-25. PubMed ID: 20590708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European guidelines for sclerotherapy in chronic venous disorders.
    Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
    Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotherapy: it is back and better.
    Mann MW
    Clin Plast Surg; 2011 Jul; 38(3):475-87, vii. PubMed ID: 21824544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing the appropriate sclerosing concentration for vessel diameter.
    Sadick NS
    Dermatol Surg; 2010 Jun; 36 Suppl 2():976-81. PubMed ID: 20590703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
    Fisher DA
    Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
    [No Abstract]   [Full Text] [Related]  

  • 11. Scrutinizing sclerotherapy.
    Bowman WE
    N C Med J; 1996; 57(3):127-8. PubMed ID: 8935354
    [No Abstract]   [Full Text] [Related]  

  • 12. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
    Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
    Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations.
    Whiteley MS; Dos Santos SJ; Fernandez-Hart TJ; Lee CT; Li JM
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):421-8. PubMed ID: 26790396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.
    Breu FX; Guggenbichler S
    Dermatol Surg; 2004 May; 30(5):709-17; discussion 717. PubMed ID: 15099312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foam sclerotherapy for the treatment of superficial venous insufficiency.
    Gibson KD; Ferris BL; Pepper D
    Surg Clin North Am; 2007 Oct; 87(5):1285-95, xii-xiii. PubMed ID: 17936487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compression sclerotherapy in venous insufficiency.
    Hobbs JT
    Acta Chir Scand Suppl; 1988; 544():75-80. PubMed ID: 3176809
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report.
    Brzoza Z; Kasperska-Zajac A; Rogala E; Rogala B
    Angiology; 2007; 58(5):644-6. PubMed ID: 18024951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.